Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Protein farnesyltransferase inhibitors from Pfizer inhibit abnormal cell growth

Aug. 11, 1999

Limonene analogue XR-3054 is a novel protein farnesyltransferase inhibitor

Aug. 11, 1999

PD-184352 inhibits growth of colon tumors in mice via interference with MAPK pathway

Aug. 11, 1999

Licensing opportunity from NIH: NAT modulators for enhancing efficacy, reducing toxicity of drugs

Aug. 11, 1999

Idec and NCI form partnership to broaden use of ibritumomab tiuxetan

Aug. 10, 1999

Licensing opportunity from NIH: improved technology for radiotherapy of cancer and other diseases

Aug. 10, 1999

Korean researchers synthesize anticancer platinum complexes

Aug. 10, 1999

NCI scientists initiate testing of thalidomide in colorectal cancer patients

Aug. 10, 1999

SCRAS team evaluates topoisomerase inhibitors for cancer indications

Aug. 10, 1999

Phase Ia results reported for Cell Pathways' novel SAAND

Aug. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...